Cargando…
Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome
Discovery of new biomarkers is critical for early diagnosis of acute coronary syndrome (ACS). Recent advances in metabolomic technologies have drastically enhanced the possibility of improving the knowledge of its physiopathology through the identification of the altered metabolic pathways. In this...
Autores principales: | Laborde, Carlos M., Mourino-Alvarez, Laura, Posada-Ayala, María, Alvarez-Llamas, Gloria, Serranillos-Reus, Manuel Gómez, Moreu, José, Vivanco, Fernando, Padial, Luis R., Barderas, María G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363481/ https://www.ncbi.nlm.nih.gov/pubmed/25814918 http://dx.doi.org/10.1007/s11306-013-0595-9 |
Ejemplares similares
-
The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome
por: Laborde, Carlos M, et al.
Publicado: (2014) -
Metabolomic Profiling for Identification of Novel Potential Biomarkers in Cardiovascular Diseases
por: Barderas, Maria G., et al.
Publicado: (2011) -
KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery
por: Martin-Lorenzo, Marta, et al.
Publicado: (2014) -
Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals
por: Baldan-Martin, Montserrat, et al.
Publicado: (2018) -
A comprehensive study of calcific aortic stenosis: from rabbit to human samples
por: Mourino-Alvarez, Laura, et al.
Publicado: (2018)